FFASIA
ALNY icon

FIG FINANCIAL ADVISORY SERVICES INC /ADV’s Alnylam Pharmaceuticals ALNY Stock Holding History

FIG FINANCIAL ADVISORY SERVICES INC /ADV’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,845
Closed -$1.13M – 63
2025
Q4 		$1.13M Buy
2,845
+33
+1% +$14.6K 0.72% 44
2025
Q3 		$1.28M Buy
+2,812
New +$1.15M 0.8% 42

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FIG FINANCIAL ADVISORY SERVICES INC /ADV's ALNY Position: Q1 2026 in Review

FIG FINANCIAL ADVISORY SERVICES INC /ADV sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2026, closing a stake of 2,845 shares — an estimated $1.13M sold.

FIG FINANCIAL ADVISORY SERVICES INC /ADV first reported a position in ALNY in Q3 2025 and held it in 2 quarters. The position peaked at $1.28M in Q3 2025. 789 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • FIG FINANCIAL ADVISORY SERVICES INC /ADV reported no remaining Alnylam Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • FIG FINANCIAL ADVISORY SERVICES INC /ADV sold 2,845 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $1.13M.
  • FIG FINANCIAL ADVISORY SERVICES INC /ADV first reported a position in Alnylam Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • FIG FINANCIAL ADVISORY SERVICES INC /ADV's Alnylam Pharmaceuticals position peaked at $1.28M in Q3 2025.
  • 789 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on FIG FINANCIAL ADVISORY SERVICES INC /ADV's 13F filing for Q1 2026, filed 10 Aug 2026.